Aug. 2, 2022
by Andrii Buvailo
Biopharma insight
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
Aug. 1, 2022
by Natalia Honchar
Biopharma insight
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
July 29, 2022
by Chris De Savi
Biopharma insight
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality …
July 28, 2022
by Natalia Honchar
Biopharma insight
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …
July 20, 2022
by Amandeep Singh
Biopharma insight
The ‘AI in Pharma’ start-up space has been rapidly exploding, with new companies being formed every month. The explosion has …
July 19, 2022
by Natalia Honchar, Andrii Buvailo
Biopharma insight
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
July 18, 2022
by Joseph Pareti
Biopharma insight
The motivation for this report In 2018, while at Supercomputing in Dallas I had a couple key encounters that profoundly …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
June 17, 2022
by Andrii Buvailo
Biopharma insight
While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving …
June 4, 2022
by Ivan Kondratov
Biopharma insight
Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is …
May 31, 2022
by Chris De Savi
Biopharma insight
The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …